Part of a bill introduced by Sens. Susan Collins (R-ME) and Tim Kaine (D-VA) that aims to increase transparency around the webs of patents that biologics manufacturers create to thwart biosimilar competition will be included in the Senate health committee’s bipartisan package on lowering health care costs, Collins’ office said Tuesday (June 25). Sens. Tina Smith (D-MN) and Mike Braun (R-IN) introduced an amendment that would alleviate generic drug makers’ concerns about the package, and Sen. Tammy Baldwin (D-WI) proposed...